Table 4.
Authors | Year | Design | Patients, n | Age, y | BMI, kg/m2 | Scoring system | End point | Prevalence, % | Cutoff, kPa | AUC | Se, % | Sp, % | Failure or unreliable, % | Probe |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Petta111 | 2015 | R | 179 | 45 ± 13 | 29.3 ± 4.1 | Kleiner | F3-F4 | 23 | 7.9/9.6 | 0.86 | 85 | 81 | 13.0 | M |
142 | 44 ± 12 | 27.4 ± 3.7 | F3-F4 | 20 | 7.9/9.6 | 0.85 | 68 | 86 | 23.0 | M | ||||
Cassinotto109 | 2016 | P | 291 | 57 ± 12 | 32.1 ± 6.0 | NASH-CRN | F3-F4 | 43 | 8.2/12.5 | 0.86 | 90/57 | 61/90 | 22.0 | M |
F4 | 17 | 9.5/16.1 | 0.87 | 92/65 | 62/90 | |||||||||
Tapper112 | 2016 | P | 164 | 51 ± 13 | 32.2a | Brunt | F3-F4 | 18 | 9.9 | 0.93 | 95 | 77 | 26.8 | M |
F4 | — | |||||||||||||
Boursier107 | 2016 | R | 452 | 56 ± 12 | 31.1 ± 5.2 | NASH-CRN | F3-F4 | 38 | 8.7 | 0.83 | 88 | 63 | 14.1 | M |
F4 | 13 | — | 0.87 | — | — | |||||||||
Imajo39 | 2016 | P | 142 (10 C) | 57 ± 15 | 28.1 ± 4.6 | Brunt | F3-F4 | 32 | 11.4 | 0.88 | 86 | 84 | 11.0 | M |
F4 | 8 | 14.0 | 0.92 | 100 | 76 | |||||||||
Petta115 | 2017 | R | 324 | 54 ± 13 | — | Kleiner | F3-F4 | 35 | 10.1 | 0.86 | 78 | 78 | — | M |
Park43 | 2017 | P | 104 | 51 ± 15 | 30.4 ± 5.2 | NASH-CRN | F3-F4 | 20 | 7.3 | 0.80 | 78 | 72 | — | M |
F4 | 8 | 6.9 | 0.69 | 63 | 66 | 6.7 | XL | |||||||
Chen110 | 2017 | P | 111 | 48a | 40.3 | Brunt | F3-F4 | 20 | 7.6 | 0.87 | 84 | 64 | — | M |
F4 | 10 | 14.6 | 0.92 | 82 | 92 | 18.7 | XL | |||||||
Petta168 | 2017 | R | 761 | 51 ± 13 | 29.6 ± 4.9 | Kleiner | F3-F4 | 31 | 7.9/9.6 | 0.86 | 90/74 | 65/81 | — | M |
Siddiqui45 | 2018 | P | 393 | 51 ± 11 | 34.4 ± 6.4 | NASH-CRN | F3-F4 | 32 | 8.6 | 0.83 | 80 | 74 | — | M |
F4 | 9 | 13.1 | 0.93 | 89 | 86 | 5.0 | XL |
AUC, area under the curve; C, controls; NASH-CRN, nonalcoholic steatohepatitis clinical research network; P, prospective; R, retrospective; Se, sensitivity; Sp, specificity.
Median.